Restless legs症候群の疾患概念

DOI

書誌事項

タイトル別名
  • Disease concept of restless legs syndrome

抄録

<p>Restless legs syndrome (RLS), also known as Willis–Ekbom disease (named after the physicians Thomas Willis and Karl–Axel Ekbom, who established its concept), is a neurological and sleep–related disorder. This sensorimotor disorder is characterized by an urge to move associated with an unpleasant sensation in the lower limbs that is present at rest and is resolved or improved by movement ; these symptoms occur in a circadian pattern, with onset in the evening or at night. Although the complete pathophysiology of RLS remains unresolved, several studies utilizing imaging, genetics, and animal models have made progress in elucidating the underlying mechanisms. Magnetic resonance imaging studies have linked RLS with reduced iron concentrations in specific brain regions, while positron emission tomography and single–photon emission computed tomography studies have demonstrated functional abnormalities in dopaminergic nerves and the mesolimbic system. Additionally, functional magnetic resonance imaging studies have demonstrated abnormalities in brain regions belonging to both the sensorimotor system and the limbic network. Recent studies have suggested that abnormalities of adenosine, dopamine, and glutamatergic innervation in the striatum could be downstream of impaired iron utilization in the brain, leading to brain iron deficiency. RLS has numerous comorbidities and may be classified as secondary. It is a complex condition in which predisposing genetic, environmental, and comorbid factors contribute to the development of the disorder. The current treatment guidelines recommend treatment initiation with low–dose dopamine agonists or gabapentin enacarbil. Although dopamine agonists are very effective during induction, their long–term use can lead to serious worsening of the disease, known as augmentation. Other treatment options include opioids, iron supplements, and other new therapeutic candidates. Nevertheless, some patients still experience poor long–term symptom management. A better understanding of the pathological mechanisms of RLS can aid new therapeutic possibilities with the emergence of new avenues of research in pharmacology.</p>

収録刊行物

  • 神経治療学

    神経治療学 40 (4), 489-493, 2023

    日本神経治療学会

詳細情報 詳細情報について

  • CRID
    1390579753348410496
  • DOI
    10.15082/jsnt.40.4_489
  • ISSN
    21897824
    09168443
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ